NCT00571610View on ClinicalTrials.gov

Montreal Safety and Efficacy of the Percutaneous Transvenous Mitral Annuloplasty Device

PHASE1CompletedINTERVENTIONAL
Enrollment

5

Participants

Timeline

Start Date

April 30, 2006

Primary Completion Date

April 30, 2008

Study Completion Date

November 30, 2008

Conditions
Heart FailureMitral Regurgitation
Interventions
DEVICE

PTMA (Percutaneous Transvenous Mitral Annuloplasty) Implant

Percutaneous access from right or left subclavian vein, diagnostic assessment, then placement of the PTMA implant in the coronary sinus, great cardiac vein.

Trial Locations (1)

H1T 1C8

Montreal Heart Institute, Montreal

All Listed Sponsors
lead

Viacor

INDUSTRY

NCT00571610 - Montreal Safety and Efficacy of the Percutaneous Transvenous Mitral Annuloplasty Device | Biotech Hunter | Biotech Hunter